Silibinin Improves TNF-α and M30 Expression and Histological Parameters in Rat Kidneys After Hepatic Ischemia/Reperfusion

REFERENCES

• Farges O, Goutte N, Bendersky N, Falissard B. Incidence and risks of liver resection: an all-inclusive French nationwide study. Ann Surg. 2012;256(5): 697-704-5. doi:10.1097/SLA.0b013e31827241d5
   Web of Science ®Google Scholar
• Pringle J H V. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48(4):541–549.
   PubMedGoogle Scholar
• Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15–G26. doi:10.1152/ajpgi.00342.2002
   PubMed Web of Science ®Google Scholar
• Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Piña E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147(1):153–159. doi:10.1016/j.jss.2007.06.015
   PubMed Web of Science ®Google Scholar
• Nastos C, Kalimeris K, Papoutsidakis N, et al. Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev. 2014;2014, Article ID 906965, 13p. doi:10.1155/2014/906965
   Web of Science ®Google Scholar
• Fondevilla C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury - a fresh look. Exp Mol Pathol. 2003;74(2):86–93. doi:10.1016/S0014-4800(03)00008-X
   PubMed Web of Science ®Google Scholar
• Rivera-Huizar S, Rincón-Sánchez AR, Covarrubias-Pinedo A, et al. Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats. Exp Toxicol Pathol. 2006;58(2–3):185–195. doi:10.1016/j.etp.2006.05.001
   PubMed Web of Science ®Google Scholar
• Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl. 2002;8(2):91–109. doi:10.1053/jlts.2002.31516
   PubMed Web of Science ®Google Scholar
• Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol. 2005;175(11):7661–7668. doi:10.4049/jimmunol.175.11.7661
   PubMed Web of Science ®Google Scholar
• Kadkhodaee M, Mikaeili S, Zahmatkesh M, et al. Alteration of renal functional, oxidative stress and inflammatory indices following hepatic ischemia-reperfusion. Gen Physiol Biophys. 2012;31(2):195–202. doi:10.4149/gpb_2012_024
   PubMed Web of Science ®Google Scholar
• Lee HT, Park SW, Kim M, D'Agati VD. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest. 2009;89(2):196–208. doi:10.1038/labinvest.2008.124
   PubMed Web of Science ®Google Scholar
• Lv J, Feng M, Zhang LL, Wan X, Zeng YC, Liang PF, Xu AP. Protective effect of epigallocatechin gallate, a major constituent of green tea, against renal ischemia–reperfusion injury in rats. Int Urol Nephrol. 2015;47:1429–1435. doi:10.1007/s11255-015-1030-0
   PubMed Web of Science ®Google Scholar
• Mohamed Abd E, Lasheen NN. Comparative study on the protective role of vitamin C and L-arginine in experimental renal ischemia reperfusion in adult rats. Int J Physiol Pathophysiol Pharmacol. 2014;6(3):153–165.
   PubMedGoogle Scholar
• Hasanvand A, Abbaszadeh A, Darabi S, Nazari A, Gholami M, Kharazmkia A. Evaluation of selenium on kidney function following ischemic injury in rats; protective effects and antioxidant activity. J Renal Inj Prev. 2017;6(2):93–98.
   PubMedGoogle Scholar
• Mira L, Silva M, Manso CF. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol. 1994;48:753–759.
   PubMed Web of Science ®Google Scholar
• Gažák R, Sedmera P, Vrbacký M, Vostálová J, Drahota Z, Marhol P, Walterová D, Křeν V. Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity—role of individual hydroxyl group. Free Radical Biol. Med. 2009;46:745–726.
   PubMed Web of Science ®Google Scholar
• Surai Peter F. Silymarin as a natural antioxidant: An overview of the current evidence and perspectives. Antioxidants (Basel). 2015;4(1):204–247.
   PubMedGoogle Scholar
• Dehmlow C, Erhard J, De Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatol. 1996;23(4):749–754. doi:10.1053/jhep.1996.v23.pm0008666328
   PubMed Web of Science ®Google Scholar
• Trappoliere M, Caligiuri A, Schmid M, et al. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol. 2009;50(6):1102–1111. doi:10.1016/j.jhep.2009.02.023
   PubMed Web of Science ®Google Scholar
• Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence V A. Milk thistle for the treatment of liver disease: A systematic review and meta-analysis. Am J Med. 2002;113(2):506–515. doi:10.1016/S0002-9343(02)01244-5
   PubMed Web of Science ®Google Scholar
• McClure J, Lovelace ES, Elahi S, et al. Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation. PLoS One. 2012;7(7). doi:10.1371/journal.pone.0041832.
   Web of Science ®Google Scholar
• Rutter K, Scherzer TM, Beinhardt S, et al. Intravenous silibinin as “rescue treatment” for on-treatment non-responders to pegylated interferon/ribavirin combination therapy. Antivir Ther. 2011;16(8):1327–1333. doi:10.3851/IMP1942
   PubMed Web of Science ®Google Scholar
• Kellici TF, Ntountaniotis D, Leonis G, et al. Investigation of the interactions of silibinin with 2-Hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods. Mol. Pharmaceutics. 2015;12(3):954–965. doi:10.1021/mp5008053
   PubMed Web of Science ®Google Scholar
• Christodoulou E, Kechagia I-A, Tzimas S, et al. Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-beta-CD lyophilized product. Int J Pharm. 2015;493(1–2):366–373. doi:10.1016/j.ijpharm.2015.07.060
   PubMed Web of Science ®Google Scholar
• Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm. 2007;67(2):531–539. doi:10.1016/j.ejpb.2007.03.005
   PubMed Web of Science ®Google Scholar
• Coulter C, Richardson C. Reported analgesic administration to rabbits, pigs, sheep, dogs and non-human primates undergoing experimental surgical procedures. Lab Anim. 2009;43(3):232.
   PubMedGoogle Scholar
• Lobetti RG, Joubert KE. Effect of administration of nonsteroidal anti-inflammatory drugs before surgery on renal function in clinically normal dogs. Am J Vet Res. 2000;61:1501–1506.
   PubMed Web of Science ®Google Scholar
• Wu J-W, Lin L-C, Hung S-C, Lin H-C, Chi C-W, Tsai T-H. Hepatobiliary excretion of silibinin in normal and liver cirrhotic rats. Drug Metab. Dispos. 2008;36(3):589–596.
   PubMed Web of Science ®Google Scholar
• Lampropoulos P, Lambropoulou M, Papalois A, Basios N, Manousi M, Simopoulos C, Tsaroucha AK. The role of apigenin in an experimental model of acute pancreatitis. J Surg Res. 2013;183:129–137.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. URL http://www.R-project.org/. R Found Stat Comput Vienna, Austria. 2015:2015. doi:10.1007/978-3-540-74686-7
   Google Scholar
• Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, Dilek ON. Changes in Hepatic TNF-α Levels, Antioxidant Status, and Oxidation Products after Renal Ischemia/Reperfusion Injury in Mice. J Surg Res. 2002;107(2):234–240. doi:10.1006/jsre.2002.6513
   PubMed Web of Science ®Google Scholar
• Wanner GA, Ertel W, Müller P, et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996;5(1):34–40.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol. 2007;71(3):817–825. doi:10.1124/mol.106.029033
   PubMed Web of Science ®Google Scholar
• Weinbroum AA, Hochhauser E, Rudick V, et al. Direct induction of acute lung and myocardial dysfunction by liver ischemia and reperfusion. J Trauma. 1997;43(4):625–627. doi:10.1097/00005373-199710000-00011
   Google Scholar
• Li X, Hassoun HT, Santora R, Rabb H. Organ crosstalk: the role of the kidney. Curr Opin Crit Care. 2009;15(6):481–487. doi:10.1097/MCC.0b013e3283379b74
   PubMed Web of Science ®Google Scholar
• Behrends M, Hirose R, Park YH, et al. Remote renal injury following partial hepatic ischemia/reperfusion injury in rats. J Gastrointest Surg. 2008;12(3):490–495. doi:10.1007/s11605-007-0252-6
   PubMed Web of Science ®Google Scholar
• Tokyol Ç, Yilmaz S, Kahraman A, Çakar H, Polat C. The effects of desferrioxamine and quercetin on liver injury induced by hepatic ischaemia-reperfusion in rats. Acta Chir Belg. 2006;106(1):68–72.
   PubMed Web of Science ®Google Scholar
• Tsaroucha AK, Tsiaousidou A, Ouzounidis N, Tsalkidou E, Lambropoulou M, Giakoustidis D, Chatzaki E, Simopoulos C. Intraperitoneal administration of apigenin in liver ischemia/reperfusion injury protective effects. Saudi J Gastroenterol. 2016;22(6):415–422. doi: 10.4103/1319-3767.195556
   PubMed Web of Science ®Google Scholar
• Abu-Amara M, Yang SY, Quaglia A, et al. Nitric oxide is an essential mediator of the protective effects of remote ischaemic preconditioning in a mouse model of liver ischaemia/reperfusion injury. Clin Sci (Lond). 2011;121(6):257–266. doi:10.1042/CS20100598
   PubMed Web of Science ®Google Scholar
• Letschert K, Faulstich H, Keller D, Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006;91(1):140–149. doi:10.1093/toxsci/kfj141
   PubMed Web of Science ®Google Scholar
• Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R. Silibinin efficacy against human hepatocellular carcinoma. Clin Cancer Res. 2005;11(23):8441–8448. doi:10.1158/1078-0432.CCR-05-1646
   PubMed Web of Science ®Google Scholar
• Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J Surg Res. 2007;143(1):58–65. doi:10.1016/j.jss.2007.03. 080.
   PubMed Web of Science ®Google Scholar
• Chu SC, Chiou HL, Chen PH, Yang SF, Hsieh YS. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol Carcinog. 2004;40(3):143–149. doi:10.1002/mc.20018
   PubMed Web of Science ®Google Scholar
• Liu BN, Han BX, Han FL. Neuroprotective effect of pAkt and HIF-1 on ischemia rats. Asian Pacific J Trop Med. 2014;221–225.
   PubMed Web of Science ®Google Scholar
• Wang M, Li YJ, Ding Y, Zhang HN, Sun T, Zhang K, Yang L, Guo YY, Liu SB, Zhao MG, Wu YM. Silibinin Prevents Autophagic Cell Death upon Oxidative Stress in Cortical Neurons and Cerebral Ischemia-Reperfusion Injury. Mol Neurobiol. 2016;53:932–943.
   PubMed Web of Science ®Google Scholar